iShares Biotechnology ETF (NASDAQ:IBB – Get Free Report) declared a dividend on Monday, March 17th, NASDAQ Dividends reports. Shareholders of record on Tuesday, March 18th will be paid a dividend of 0.1212 per share by the financial services provider on Friday, March 21st. The ex-dividend date of this dividend is Tuesday, March 18th. This is a 94.3% increase from iShares Biotechnology ETF’s previous dividend of $0.06.
iShares Biotechnology ETF Price Performance
iShares Biotechnology ETF stock traded down $2.01 during trading hours on Tuesday, reaching $134.09. The company had a trading volume of 509,360 shares, compared to its average volume of 1,325,954. The company has a 50-day moving average price of $136.28 and a 200 day moving average price of $139.67. The firm has a market cap of $6.34 billion, a price-to-earnings ratio of 24.52 and a beta of 0.84. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57.
Hedge Funds Weigh In On iShares Biotechnology ETF
An institutional investor recently bought a new position in iShares Biotechnology ETF stock. Brighton Jones LLC purchased a new position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,517 shares of the financial services provider’s stock, valued at approximately $201,000. 62.45% of the stock is owned by institutional investors.
iShares Biotechnology ETF Company Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Read More
- Five stocks we like better than iShares Biotechnology ETF
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Investing in the High PE Growth Stocks
- 3 Must-Own Stocks to Build Wealth This Decade
- What Are Dividend Contenders? Investing in Dividend Contenders
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
